Premium
Genetic Test Results and Disclosure to Family Members: Qualitative Interviews of Healthcare Professionals’ Perceptions of Ethical and Professional Issues in France
Author(s) -
d’ Audiffret Van Haecke Diane,
Montgolfier Sandrine
Publication year - 2016
Publication title -
journal of genetic counseling
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.867
H-Index - 52
eISSN - 1573-3599
pISSN - 1059-7700
DOI - 10.1007/s10897-015-9896-7
Subject(s) - next of kin , genetic counseling , geneticist , framing (construction) , qualitative research , genetic testing , legislation , health care , perception , medicine , medical prescription , family medicine , nursing , test (biology) , psychology , political science , sociology , social science , genetics , structural engineering , neuroscience , law , biology , engineering , paleontology
The benefit of disclosing test results to next of kin is to improve prognosis and—in some cases—even prevent death though earlier monitoring or preventive therapies. Research on this subject has explored the question of intra‐familial communication from the standpoint of patients and relatives but rarely, from the standpoint of healthcare professionals. The purpose of this study was to interview relevant healthcare professionals in France, where legislation framing the issue was recently passed. A qualitative study consisting of semi‐structured interviews was set up to get a clearer picture of the challenges arising from this issue, its consequences in terms of medical care‐service practices, and the positions that frontline professionals have taken in response to this new legal framework. The findings from eight interviews with 7 clinical geneticists and 1 genetic counselor highlight very different patterns of practices among care services and among the genetic diseases involved. It is equally crucial to investigate other issues such as the nature of genetic testing and its consequences in terms of disclosing results to kin, the question of the role of genetic counseling in the disclosure process, the question of prescription by non‐geneticist clinicians, and practical questions linked to information content, consent and medical follow‐up for patients and their relatives.